|
Volumn 38, Issue 9, 2020, Pages 2144-2148
|
Finding equipoise: CEPI revises its equitable access policy
|
Author keywords
Emerging infectious diseases; Epidemic preparedness; Equitable Access; Vaccine development
|
Indexed keywords
LASSA FEVER VIRUS VACCINE;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS VACCINE;
NIPAH VIRUS VACCINE;
RIFT VALLEY FEVER VIRUS VACCINE;
UNCLASSIFIED DRUG;
VIRUS VACCINE;
CHIKUNGUNYA VIRUS;
COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS;
DRUG RESEARCH;
EPIDEMIC;
EQUIPOISE;
HEALTH CARE ACCESS;
HEALTH CARE FINANCING;
HEALTH CARE POLICY;
HUMAN;
LASSA VIRUS;
LOW INCOME COUNTRY;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
MIDDLE INCOME COUNTRY;
NIPAH VIRUS;
PRESCRIPTION;
PRIORITY JOURNAL;
PUBLIC-PRIVATE PARTNERSHIP;
REVIEW;
RIFT VALLEY FEVER VIRUS;
STAKEHOLDER ENGAGEMENT;
DRUG DEVELOPMENT;
ECONOMICS;
INTERNATIONAL COOPERATION;
ORGANIZATION;
DISEASE OUTBREAKS;
DRUG DEVELOPMENT;
HUMANS;
INTERNATIONAL COOPERATION;
ORGANIZATIONS;
VIRAL VACCINES;
|
EID: 85078413358
PISSN: 0264410X
EISSN: 18732518
Source Type: Journal
DOI: 10.1016/j.vaccine.2019.12.055 Document Type: Review |
Times cited : (9)
|
References (3)
|